Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Global Health Solutions Inc. currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active matter is being handled by a distinct examiner within a particular art unit. This arrangement suggests a very specific and focused area of interest for the company's current patenting activities. The lack of other pending matters allows the company to dedicate its full attention to the resolution of this particular case.
FOLEY, SHANON A is the busiest examiner for the company, holding 1 pending office action. Because the portfolio has only a specific active matter, this examiner is the sole individual currently reviewing the company's patent claims. The success of the company's immediate prosecution strategy depends entirely on the resolution of the issues raised in this 1 office action. Practitioners should focus on addressing the specific technical objections of the examiner to ensure the successful advancement of the application.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOLEY, SHANON A | 1 | 73.3% | +18.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19295239 | THERMOSTABLE MUCOSAL VACCINE COMPOSITIONS AND METHODS | FOLEY, SHANON A | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19295239 | THERMOSTABLE MUCOSAL VACCINE COMPOSITIONS AND METHODS | FOLEY, SHANON A | 34d |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19295239 | THERMOSTABLE MUCOSAL VACCINE COMPOSITIONS AND METHODS | FOLEY, SHANON A | 1671 | §103§112 | Non-Final OA | 34d | Pending | Aug 08, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial